These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 36484017)

  • 21. Registries and Cohorts to Accelerate Early Phase Alzheimer's Trials. A Report from the E.U./U.S. Clinical Trials in Alzheimer's Disease Task Force.
    Aisen P; Touchon J; Andrieu S; Boada M; Doody R; Nosheny RL; Langbaum JB; Schneider L; Hendrix S; Wilcock G; Molinuevo JL; Ritchie C; Ousset PJ; Cummings J; Sperling R; DeKosky ST; Lovestone S; Hampel H; Petersen R; Legrand V; Egan M; Randolph C; Salloway S; Weiner M; Vellas B
    J Prev Alzheimers Dis; 2016; 3(2):68-74. PubMed ID: 29210442
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modifiable dementia risk factors and AT(N) biomarkers: findings from the EPAD cohort.
    Roccati E; Bindoff AD; Collins JM; Eastgate J; Borchard J; Alty J; King AE; Vickers JC; Carboni M; Logan C;
    Front Aging Neurosci; 2024; 16():1346214. PubMed ID: 38384935
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Patient Engagement: The Fundació ACE Framework for Improving Recruitment and Retention in Alzheimer's Disease Research.
    Boada M; Santos-Santos MA; Rodríguez-Gómez O; Alegret M; Cañabate P; Lafuente A; Abdelnour C; Buendía M; de Dios MJ; Morera A; Sanabria Á; Campo L; Ruiz A; Tárraga L
    J Alzheimers Dis; 2018; 62(3):1079-1090. PubMed ID: 29562541
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The MOPEAD project: Advancing patient engagement for the detection of "hidden" undiagnosed cases of Alzheimer's disease in the community.
    Rodríguez-Gómez O; Rodrigo A; Iradier F; Santos-Santos MA; Hundemer H; Ciudin A; Sannemann L; Zwan M; Glaysher B; Wimo A; Bonn J; Johansson G; Rodriguez I; Alegret M; Gove D; Pinó S; Trigueros P; Kivipelto M; Mathews B; Ciudad A; Ferreira D; Bintener C; Gurruchaga M; Westman E; Belger M; Valero S; Maguire P; Krivec D; Kramberger M; Simó R; Garro IP; Visser PJ; Dumas A; Georges J; Jessen F; Winblad B; Shering C; Stewart N; Campo L; Boada M;
    Alzheimers Dement; 2019 Jun; 15(6):828-839. PubMed ID: 31076376
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Disease Modelling of Cognitive Outcomes and Biomarkers in the European Prevention of Alzheimer's Dementia Longitudinal Cohort.
    Howlett J; Hill SM; Ritchie CW; Tom BDM
    Front Big Data; 2021; 4():676168. PubMed ID: 34490422
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preclinical Alzheimer's disease and its outcome: a longitudinal cohort study.
    Vos SJ; Xiong C; Visser PJ; Jasielec MS; Hassenstab J; Grant EA; Cairns NJ; Morris JC; Holtzman DM; Fagan AM
    Lancet Neurol; 2013 Oct; 12(10):957-65. PubMed ID: 24012374
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Systems Biology Methods for Alzheimer's Disease Research Toward Molecular Signatures, Subtypes, and Stages and Precision Medicine: Application in Cohort Studies and Trials.
    Castrillo JI; Lista S; Hampel H; Ritchie CW
    Methods Mol Biol; 2018; 1750():31-66. PubMed ID: 29512064
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The project data sphere initiative: accelerating cancer research by sharing data.
    Green AK; Reeder-Hayes KE; Corty RW; Basch E; Milowsky MI; Dusetzina SB; Bennett AV; Wood WA
    Oncologist; 2015 May; 20(5):464-e20. PubMed ID: 25876994
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ethical Issues in the Development of Readiness Cohorts in Alzheimer's Disease Research.
    Milne R; Bunnik E; Tromp K; Bemelmans S; Badger S; Gove D; Maman M; Schermer M; Truyen L; Brayne C; Richard E
    J Prev Alzheimers Dis; 2017; 4(2):125-131. PubMed ID: 29186282
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rationale and design of the ABOARD project (A Personalized Medicine Approach for Alzheimer's Disease).
    Dreves MAE; van Harten AC; Visser LNC; Rhodius-Meester H; Köhler S; Kooistra M; Papma JM; Honey MIJ; Blom MM; Smets EMA; de Vugt ME; Teunissen CE; van der Flier WM;
    Alzheimers Dement (N Y); 2023; 9(2):e12401. PubMed ID: 37287472
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Return on investment in science: twenty years of European Commission funded research in Alzheimer's dementia, breast cancer and prostate cancer.
    Jakovljevic M; Deceuninck P; Pistollato F; Daskalopoulos E; Bernasconi C; Carausu F; Rosa M; Progri A; Makarieva M; Krstic K
    Cost Eff Resour Alloc; 2024 Jun; 22(1):51. PubMed ID: 38880873
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Alzheimer's Prevention Initiative Generation Program: Study design of two randomized controlled trials for individuals at risk for clinical onset of Alzheimer's disease.
    Lopez Lopez C; Tariot PN; Caputo A; Langbaum JB; Liu F; Riviere ME; Langlois C; Rouzade-Dominguez ML; Zalesak M; Hendrix S; Thomas RG; Viglietta V; Lenz R; Ryan JM; Graf A; Reiman EM
    Alzheimers Dement (N Y); 2019; 5():216-227. PubMed ID: 31211217
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The European medical information framework: A novel ecosystem for sharing healthcare data across Europe.
    Lovestone S;
    Learn Health Syst; 2020 Apr; 4(2):e10214. PubMed ID: 32313838
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Innovative Medicines Initiative's New Drugs for Bad Bugs programme: European public-private partnerships for the development of new strategies to tackle antibiotic resistance.
    Kostyanev T; Bonten MJ; O'Brien S; Steel H; Ross S; François B; Tacconelli E; Winterhalter M; Stavenger RA; Karlén A; Harbarth S; Hackett J; Jafri HS; Vuong C; MacGowan A; Witschi A; Angyalosi G; Elborn JS; deWinter R; Goossens H
    J Antimicrob Chemother; 2016 Feb; 71(2):290-5. PubMed ID: 26568581
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Associations Between Multimorbidity and Cerebrospinal Fluid Amyloid: A Cross-Sectional Analysis of the European Prevention of Alzheimer's Dementia (EPAD) V500.0 Cohort.
    Stirland LE; Russ TC; Ritchie CW; Muniz-Terrera G;
    J Alzheimers Dis; 2019; 71(2):703-711. PubMed ID: 31424394
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Souvenaid for Alzheimer's disease.
    Burckhardt M; Watzke S; Wienke A; Langer G; Fink A
    Cochrane Database Syst Rev; 2020 Dec; 12(12):CD011679. PubMed ID: 33320335
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aerobic and strength training exercise programme for cognitive impairment in people with mild to moderate dementia: the DAPA RCT.
    Lamb SE; Mistry D; Alleyne S; Atherton N; Brown D; Copsey B; Dosanjh S; Finnegan S; Fordham B; Griffiths F; Hennings S; Khan I; Khan K; Lall R; Lyle S; Nichols V; Petrou S; Zeh P; Sheehan B
    Health Technol Assess; 2018 May; 22(28):1-202. PubMed ID: 29848412
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Precision medicine in neurodegeneration: the IHI-PROMINENT project.
    Tate A; Suárez-Calvet M; Ekelund M; Eriksson S; Eriksdotter M; Van Der Flier WM; Georges J; Kivipelto M; Kramberger MG; Lindgren P; López JDG; Lötjönen J; Persson S; Pla S; Solomon A; Thurfjell L; Wimo A; Winblad B; Jönsson L;
    Front Neurol; 2023; 14():1175922. PubMed ID: 37602259
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.